TITLE
ERalpha-negative ERbeta-positive breast carcinoma response to tamoxifen

SUMMARY
Analysis of estrogen receptor (ER) alpha negative ERbeta-positive breast cancer tumors from patients treated with tamoxifen for 2 years. Unlike ERalpha-negative ERbeta-negative breast cancers, ERalpha-negative ERbeta-positive cancers respond favorably to tamoxifen treatment.

ORGANISM
Homo sapiens

PLATFORM
GPL3883 : Swegene Human 27K RAP UniGene188 array

CITATIONS
Gruvberger-Saal SK, Bendahl PO, Saal LH, Laakso M et al. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin Cancer Res 2007 Apr 1;13(7):1987-94. PMID:Â  17404078

